OriGene Raises $16M to Continue Building Antibody Collection

According to the company — whose goal is to build a monoclonal antibody collection that will cover most of the human proteome — its TrueMab monoclonal antibody collection is "far superior in quality" to small peptide-generated antibodies.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.